Berberine for Adjunct/Alternative Treatment of Dyslipidemia: A Literature Review

Berberine (BBR) is an ancient plant popular in China and is used to treat dyslipidemia, among other cardiovascular and metabolic-related diseases. BBR has historically been regarded as having multiple benefits, with a few clinical trials indicating this fact. We searched PubMed, Embase, and Google S...

Descripción completa

Detalles Bibliográficos
Autores principales: Evbayekha, Endurance O, Nwachukwu, Elochukwu U, Nikravesh, Elham, Rosas, Valene, Onuegbu, Chinwendu A, Egwuonwu, Obinna F, Eguagie, Osazee, Chioma, Ogochukwu E, Agho, Awanwosa V, Samuels, Kemar A, Willie, Anthony, Nwafor, Jane N, Esene-Akhideno, Laura N, Adigun, Aisha O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279928/
https://www.ncbi.nlm.nih.gov/pubmed/37346213
http://dx.doi.org/10.7759/cureus.39261
Descripción
Sumario:Berberine (BBR) is an ancient plant popular in China and is used to treat dyslipidemia, among other cardiovascular and metabolic-related diseases. BBR has historically been regarded as having multiple benefits, with a few clinical trials indicating this fact. We searched PubMed, Embase, and Google Scholar with the following keywords: Berberidaceae, berberine, Berberis spp., dyslipidemia, atherosclerosis, and inflammation. We synthesized the information within the literature to provide an updated review of BBR, its potential, and its applicability in real-world medicine in the future. This review sought to evaluate the literature and advancement in BBR’s efficacy regarding dyslipidemia, inflammation, and atherosclerosis.

Ejemplares similares